Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Tatsuji Mino"'
Autor:
Taro Edahiro, Hiroshi Ureshino, Ren Chishaki, Keita Fujino, Tatsuji Mino, Tetsumi Yoshida, Noriyasu Fukushima, Tatsuo Ichinohe
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 273-275 (2023)
Abstract Translocation t(6;11) occurs in approximately 5% of patients with acute myeloid leukemia (AML) corresponding to 11q23/mixed lineage leukemia (MLL) rearrangement. The AF6 gene on chromosome 6q27 is the fusion partner of the MLL gene on 11q23
Externí odkaz:
https://doaj.org/article/e94876733feb4e538b5ba49a299f6e09
Autor:
Taro Edahiro, Hiroshi Ureshino, Ren Chishaki, Keita Fujino, Tatsuji Mino, Tetsumi Yoshida, Noriyasu Fukushima, Tatsuo Ichinohe
Publikováno v:
eJHaem. 4:273-275
Autor:
Taro Edahiro, Noriyasu Fukushima, Tatsuya Otani, Masahiro Nakamori, Kazuo Nakamichi, Ren Chishaki, Keita Fujino, Tatsuji Mino, Tetsumi Yoshida, Sayaka Sugihara, Masatoshi Nishizawa, Tatsuo Ichinohe
Publikováno v:
Acta Haematologica. 145:655-661
Progressive multifocal leukoencephalopathy (PML) is a rare neurological disease caused by the reactivation of latent John Cunningham polyomavirus. Hematological disorders associated with immunomodulatory monoclonal antibodies and hematopoietic stem c
Autor:
Taro Edahiro, Hiroshi Ureshino, Ren Chishaki, Keita Fujino, Tatsuji Mino, Tetsumi Yoshida, Noriyasu Fukushima, Tatsuo Ichinohe
Publikováno v:
Internal Medicine.
Patients with acute myeloid leukemia (AML) harboring FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication mutation are associated with a poor survival outcome, even those receiving allogeneic stem cell transplantation (Allo-SCT). An addition
Autor:
Taro Edahiro, Hiroshi Ureshino, Ren Chishaki, Keita Fujino, Tatsuji Mino, Tetsumi Yoshida, Noriyasu Fukushima, Tatsuo Ichinohe
Publikováno v:
Leukemia & Lymphoma. 63:3511-3512
Publikováno v:
Cureus.
Autor:
Tatsuo Ichinohe, Keita Fujino, Masatoshi Nishizawa, Takahiko Miyama, Takehiko Morioka, Hisao Nagoshi, Teruhisa Fujii, Taro Edahiro, Yuji Hirata, Noriyasu Fukushima, Tatsuji Mino, Tetsumi Yoshida, Takakazu Kawase, Mitsunori Noma, Kayo Toishigawa
Publikováno v:
Hematology (Amsterdam, Netherlands). 26(1)
Optimal selection of pretransplant conditioning is crucially vital for improving survival and quality-of-life of patients who receive allogeneic hematopoietic cell transplantation (allo-HCT), particularly in those with high-risk diseases. In this stu
Publikováno v:
Annals of Hematology. 93:1937-1939
Autor:
Fumiaki Jinnouchi, Hideki Asaoku, Ryota Imanaka, Koji Iwato, Shinya Katsutani, Yu Kochi, Tatsuji Mino, Tasuya Terasaki, Yoshimasa Suetsugu, Mitsuhiro Itagaki, Takeshi Okatani, Kohei Kyo, Tsuyoshi Muta, Masaaki Noda, Yuta Katayama
Publikováno v:
Blood. 132:5321-5321
Background: Follicular lymphoma (FL) shows indolent clinical course and the optimal management strategy includes watchful waiting (WW). To define prognostic models for WW in clinical practice, we focused on serum soluble interleukin-2 receptor (sIL-2
Autor:
Koji Iwato, Tsuyoshi Muta, Fumiaki Jinnouchi, Hideki Asaoku, Yuta Katayama, Shinya Katsutani, Takeshi Okatani, Yu Kochi, Kohei Kyo, Tatsuya Terasaki, Tatsuji Mino, Mitsuhiro Itagaki, Ryota Imanaka
Publikováno v:
Blood. 132:2095-2095
Background: Indications for allogeneic hematopoietic stem cell transplantation (allo-HCT) with reduced-intensity conditioning (RIC) have expanded widely for elderly patients and those with comorbidities. However, the optimal RIC regimen remains uncer